会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 65. 发明专利
    • Piperazine derivative and its acid adduct
    • 哌嗪衍生物及其添加剂
    • JPS60193978A
    • 1985-10-02
    • JP4796584
    • 1984-03-13
    • Mitsubishi Chem Ind Ltd
    • FUKAMI JIICHIINOUE SHINYANITSUTA KAZUMASANAKAO KENICHIROUKIKUMOTO RIYOUJI
    • C07D295/08A61K31/495A61K31/625A61P9/12C07D213/74C07D295/10
    • NEW MATERIAL:A compound of formula I [R
      1 is OR
      3 , NR
      3 R
      4 (R
      3 , R
      4 are H, 1W3C alkyl); R
      2 is H, 1W3C alkyl; X is -C(=O)-; Ar is pyridyl, phenyl which may be substituted with halogen or 1W3C alkyl; n is 3, 4, 5] and its acid adduct.
      EXAMPLE: 5-[5-(4-Phenyl-1-piperazinyl)valeryl]salicylamide.
      USE: Hypotensor: it develops satisfactory hypotensive effect with a small amount of administration, further its development is prompt and durative. Further, its high safety is suggested.
      PREPARATION: The reaction of an ω-halogenoalkanoylbenzene of formula II (X is halogen) with a piperazine of formula III gives the compound of formula I . The stoichiometric relation between the two reactants is 1:1, but the use of excessive amount of piperazine helps the smooth progress of the reaction and so the piperazine is used by 1W10mol per mol of the compound of formula II.
      COPYRIGHT: (C)1985,JPO&Japio
    • 新材料:式I化合物[R 1]为OR 3,NR 3 R 4(R 3,R 4为H,1-3C烷基); R 2是H,1-3C烷基; X是-C(= O) - ; Ar是吡啶基,可被卤素或1-3C烷基取代的苯基; n为3,4,5]及其酸加合物。 实施例:5- [5-(4-苯基-1-哌嗪基)戊酰基]水杨酰胺。 用途:低血压药物:少量给药可以发挥令人满意的降压作用,进一步发展是及时和持续的。 此外,建议其高安全性。 制备:式II的ω-卤代烷酰基苯(X为卤素)与式III的哌嗪的反应得到式I化合物。 两种反应物之间的化学计量关系为1:1,但使用过量的哌嗪有助于反应的顺利进行,因此哌嗪的用量为每摩尔式Ⅱ化合物1-10摩尔。
    • 66. 发明专利
    • Biosynthetic inhibitor for fatty acid
    • 脂肪酸的生物活性抑制剂
    • JPS59164716A
    • 1984-09-17
    • JP3860383
    • 1983-03-09
    • Mitsubishi Chem Ind Ltd
    • ENDOU AKIRANITSUTA KAZUMASAMARUYAMA AKIRA
    • A61K31/19A61P43/00C07C51/00C07C55/02C07C57/13C07C67/00C12N9/99
    • PURPOSE: A biosynthetic inhibitor for fatty acids, containing a specific dicarboxylic acid as an active constituent, and capable of inhibiting acetyl CoA carboxylase and treating obesity due to excess fat causing arteriosclerosis, diabetes, etc.
      CONSTITUTION: A biosynthetic inhibitor for fatty acids containing a dicarboxylic acid of the formula (R is alkyl or alkenyl; n is 0 or an integer 1W6), anhydride or a salt thereof as an active constituent. The compound of the formula is capable of inhibiting acetyl CoA carboxylase which is a rate determining enzyme of a synthetic system for the fatty acids. Thus, the accumulation of excess fat which is a direct or indirect cause for arteriosclerosis, diabetes or gout, etc. having a tendency to cause complication is inhibited. The above-mentioned inhibitor can be orally or parenterally administered. The daily dose thereof is usually 0.1W2,000mg/kg. The compound of the formula can be produced by the well-known method.
      COPYRIGHT: (C)1984,JPO&Japio
    • 目的:一种脂肪酸的生物合成抑制剂,其含有特定的二羧酸作为活性成分,能够抑制乙酰辅酶A羧化酶和治疗由于过量脂肪引起的动脉硬化,糖尿病等引起的肥胖。构成:含有 二羧酸(R是烷基或烯基; n是0或1-6的整数),酸酐或其盐作为活性成分。 该化合物能够抑制作为脂肪酸合成体系的速率决定酶的乙酰辅酶A羧化酶。 因此,抑制作为导致并发症的倾向的动脉硬化,糖尿病或痛风等的直接或间接原因的过量脂肪的积聚。 上述抑制剂可以口服或肠胃外给药。 其日剂量通常为0.1〜2,000mg / kg。 式的化合物可以通过公知的方法制备。